KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Gentex (GNTX) EBT (2016 - 2025)

Gentex (GNTX) has disclosed EBT for 17 consecutive years, with $111.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 13.92% year-over-year to $111.4 million, compared with a TTM value of $461.1 million through Dec 2025, down 2.36%, and an annual FY2025 reading of $461.1 million, down 2.36% over the prior year.
  • EBT was $111.4 million for Q4 2025 at Gentex, down from $120.6 million in the prior quarter.
  • Across five years, EBT topped out at $145.5 million in Q3 2024 and bottomed at $84.8 million in Q2 2022.
  • Average EBT over 5 years is $111.2 million, with a median of $112.5 million recorded in 2025.
  • Peak annual rise in EBT hit 2729.52% in 2021, while the deepest fall reached 46.0% in 2021.
  • Year by year, EBT stood at $89.4 million in 2021, then grew by 6.81% to $95.5 million in 2022, then skyrocketed by 42.37% to $135.9 million in 2023, then decreased by 28.05% to $97.8 million in 2024, then rose by 13.92% to $111.4 million in 2025.
  • Business Quant data shows EBT for GNTX at $111.4 million in Q4 2025, $120.6 million in Q3 2025, and $115.5 million in Q2 2025.